Episode 559: SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes

POEM of the Week Podcast - Een podcast door Mark Ebell and Michael Wilkes

Probeer Podimo de eerste 30 dagen gratis gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

Sponsored

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes '

Visit the podcast's native language site